
Effective antiviral agents are urgently required to prevent and treat individuals infected with SARS-CoV-2 and other emerging viral infections. The COVID-19 pandemic has catapulted our efforts to identify, develop, and evaluate several antiviral agents.
IFN lambda, mouse model, interferon lambda, Antiviral Agents, murine model, Interferon Lambda, MERS-CoV, Mice, inflammation, Middle East Respiratory Syndrome Coronavirus, Animals, Humans, Interferons, hCoV-229E, Coronavirus Infections, KEYWORDS human coronavirus
IFN lambda, mouse model, interferon lambda, Antiviral Agents, murine model, Interferon Lambda, MERS-CoV, Mice, inflammation, Middle East Respiratory Syndrome Coronavirus, Animals, Humans, Interferons, hCoV-229E, Coronavirus Infections, KEYWORDS human coronavirus
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
